British American Tobacco p.l.c. (BTI) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Feb 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BTI SEC filings page.
British American Tobacco p.l.c. (BTI) reported $34.4B in revenue for fiscal year 2025, up 6.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of British American Tobacco p.l.c.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
British American Tobacco p.l.c. has an operating margin of 39.0%, meaning the company retains $39 of operating profit per $100 of revenue. This results in a moderate score of 51/100, indicating healthy but not exceptional operating efficiency. This is up from 10.6% the prior year.
British American Tobacco p.l.c.'s revenue grew 6.3% year-over-year to $34.4B, a solid pace of expansion. This earns a growth score of 29/100.
British American Tobacco p.l.c. has elevated debt relative to equity (D/E of 0.69), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 28/100, reflecting increased financial risk.
British American Tobacco p.l.c.'s current ratio of 0.87 is below the typical benchmark, resulting in a score of 14/100. This tight liquidity could limit financial flexibility if cash inflows slow.
British American Tobacco p.l.c. converts 22.6% of revenue into free cash flow ($7.8B). This strong cash generation earns a score of 94/100.
British American Tobacco p.l.c.'s ROE of 16.9% shows moderate profitability relative to equity, earning a score of 31/100. This is up from 6.4% the prior year.
British American Tobacco p.l.c. scores 1.73, below the 1.81 distress threshold. The score is pulled down most by current liabilities exceeding current assets by $2.5B against total assets of $147.0B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
British American Tobacco p.l.c. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, British American Tobacco p.l.c. generates $0.82 in operating cash flow ($8.5B OCF vs $10.4B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
British American Tobacco p.l.c. earns $6.03 in operating income for every $1 of interest expense ($13.4B vs $2.2B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
British American Tobacco p.l.c. generated $34.4B in revenue in fiscal year 2025. This represents an increase of 6.3% from the prior year.
British American Tobacco p.l.c.'s EBITDA was $16.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 130.8% from the prior year.
British American Tobacco p.l.c. reported $10.4B in net income in fiscal year 2025. This represents an increase of 171.8% from the prior year.
British American Tobacco p.l.c. earned $4.69 per diluted share (EPS) in fiscal year 2025. This represents an increase of 175.7% from the prior year.
Cash & Balance Sheet
British American Tobacco p.l.c. generated $7.8B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 35.5% from the prior year.
British American Tobacco p.l.c. held $5.1B in cash against $42.6B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
British American Tobacco p.l.c.'s operating margin was 39.0% in fiscal year 2025, reflecting core business profitability. This is up 28.5 percentage points from the prior year.
British American Tobacco p.l.c.'s net profit margin was 30.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 18.5 percentage points from the prior year.
British American Tobacco p.l.c.'s ROE was 16.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 10.5 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
British American Tobacco p.l.c. invested $481.4M in research and development in fiscal year 2025. This represents an increase of 1.2% from the prior year.
British American Tobacco p.l.c. spent $82.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 30.3% from the prior year.
British American Tobacco p.l.c. invested $740.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 21.8% from the prior year.
BTI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.4B+6.3% | $32.4B-6.8% | $34.8B+4.1% | $33.4B-3.7% | $34.7B-1.5% | $35.2B+2.6% | $34.3B+9.8% | $31.3B+18.1% | $26.5B+51.8% | $17.4B-5.7% | $18.5B |
| R&D Expenses | $481.4M+1.2% | $475.8M-8.5% | $519.9M+33.3% | $390.1M-4.9% | $410.4M-2.2% | $419.4M-15.9% | $498.9M+51.5% | $329.3M+27.4% | $258.4M+45.5% | $177.7M+100.8% | $88.5M |
| Operating Income | $13.4B+292.4% | $3.4Bn/m | -$20.1B-257.9% | $12.7B-8.0% | $13.8B+1.5% | $13.6B+13.8% | $12.0B+0.6% | $11.9B+37.0% | $8.7B+51.1% | $5.7B-14.5% | $6.7B |
| EBITDA | $16.9B+130.8% | $7.3B-55.4% | $16.4B+14.7% | $14.3B-6.4% | $15.3B-2.1% | $15.6B+11.6% | $14.0B+5.7% | $13.2B+33.5% | $9.9B+52.4% | $6.5B-11.7% | $7.4B |
| Interest Expense | $2.2B+4.5% | $2.1B-6.3% | $2.3B+17.6% | $1.9B-0.2% | $1.9B-11.6% | $2.2B-1.4% | $2.2B+9.5% | $2.0B+39.2% | $1.5B+83.5% | $795.7M-5.8% | $844.9M |
| Income Tax | $2.8B+529.9% | $447.0Mn/m | -$3.7B-222.3% | $3.0B+1.3% | $3.0B+2.6% | $2.9B+5.2% | $2.7B+0.2% | $2.7Bn/m | -$11.0B-734.0% | $1.7B-11.8% | $2.0B |
| Net Income | $10.4B+171.8% | $3.8Bn/m | -$18.3B-327.4% | $8.1B-12.3% | $9.2B+5.0% | $8.7B+15.5% | $7.6B-1.7% | $7.7B-84.8% | $50.7B+784.4% | $5.7B-9.4% | $6.3B |
| EPS (Basic) | $4.72+175.8% | $1.71n/m | -$8.24-332.6% | $3.54-11.6% | $4.01+4.8% | $3.83 | $3.31 | $3.37-86.4% | $24.81+703.8% | $3.09 | $340.49 |
| EPS (Diluted) | $4.69+175.7% | $1.70n/m | -$8.24-333.7% | $3.53-11.7% | $3.99+4.7% | $3.81 | $3.30 | $3.36-86.4% | $24.73+704.2% | $3.07 | $339.60 |
| Diluted Shares (Avg) | 2.20B-1.2% | 2.23B-0.2% | 2.23B-1.7% | 2.27B-1.3% | 2.30B+0.1% | 2.29B | 2.29B | 2.29B | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, SG&A Expenses.
BTI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $147.0B-1.3% | $148.9B-1.6% | $151.3B-18.4% | $185.4B0.0% | $185.4B-1.4% | $188.1B+0.5% | $187.1B+0.2% | $186.8B-2.1% | $190.8B+288.9% | $49.1B | N/A |
| Current Assets | $17.1B-4.7% | $17.9B-1.0% | $18.1B-2.9% | $18.6B+7.6% | $17.3B-7.0% | $18.6B+5.6% | $17.6B+9.0% | $16.2B-14.5% | $18.9B+23.9% | $15.2B | N/A |
| Cash & Equivalents | $5.1B-22.4% | $6.6B+11.7% | $5.9B+42.7% | $4.2B+9.7% | $3.8B-11.6% | $4.3B+27.9% | $3.4B+0.9% | $3.3B-25.4% | $4.5B+63.7% | $2.7B | N/A |
| Inventory | $5.9B+2.0% | $5.8B-8.1% | $6.3B-8.1% | $6.8B-3.9% | $7.1B-13.0% | $8.2B+1.3% | $8.1B+5.1% | $7.7B-3.0% | $7.9B+11.0% | $7.1B | N/A |
| Accounts Receivable | $5.1B+13.3% | $4.5B-2.2% | $4.6B-12.5% | $5.3B-1.1% | $5.3B+4.9% | $5.1B-6.4% | $5.4B+18.6% | $4.6B-16.5% | $5.5B+14.4% | $4.8B | N/A |
| Goodwill | $52.3B+1.6% | $51.5B-1.7% | $52.4B-9.6% | $57.9B-0.7% | $58.3B-1.5% | $59.2B+0.6% | $58.8B-0.2% | $58.9B-1.4% | $59.7B+339.2% | $13.6B-1.1% | $13.7B |
| Total Liabilities | $85.1B-4.2% | $88.8B+2.8% | $86.4B-10.4% | $96.5B-0.7% | $97.1B-5.2% | $102.5B+0.2% | $102.3B-0.9% | $103.3B-5.0% | $108.6B+178.7% | $39.0B | N/A |
| Current Liabilities | $19.5B-16.8% | $23.5B+17.5% | $20.0B-7.4% | $21.6B+5.5% | $20.4B-3.3% | $21.1B-15.3% | $25.0B+19.8% | $20.8B-1.3% | $21.1B+44.3% | $14.6B | N/A |
| Non-Current Liabilities | $62.7B-0.2% | $62.8B-1.6% | $63.9B-11.9% | $72.4B-2.1% | $74.0B-8.6% | $81.0B+5.2% | $77.0B-6.2% | $82.1B-5.9% | $87.2B+262.3% | $24.1B | N/A |
| Long-Term Debt | $42.6B+4.3% | $40.9B-9.4% | $45.1B-3.5% | $46.8B-2.9% | $48.1B-11.7% | $54.5B+8.7% | $50.2B-9.2% | $55.2B-7.3% | $59.6B+192.8% | $20.3B | N/A |
| Total Equity | $61.9B+3.1% | $60.0B-7.4% | $64.8B-27.1% | $89.0B+0.8% | $88.3B+3.1% | $85.6B+1.0% | $84.8B+1.5% | $83.5B+1.6% | $82.2B+714.3% | $10.1B+36.0% | $7.4B |
| Retained Earnings | $30.8B+14.0% | $27.1B-13.4% | $31.3B-41.3% | $53.2B-10.8% | $59.7B+3.9% | $57.4B+7.6% | $53.4B+8.5% | $49.2B-1.5% | $50.0B+1116.0% | $4.1B | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
BTI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.5B-32.7% | $12.7B-7.1% | $13.7B+8.8% | $12.6B-4.3% | $13.1B-1.9% | $13.4B+12.0% | $11.9B-9.2% | $13.1B+81.6% | $7.2B+27.2% | $5.7B-18.3% | $7.0B |
| Depreciation & Amortization | $3.4B-11.8% | $3.9B-89.4% | $36.5B+2213.6% | $1.6B+8.5% | $1.5B-26.7% | $2.0B-1.3% | $2.0B+51.4% | $1.3B+8.6% | $1.2B+63.0% | $748.9M+18.7% | $631.1M |
| Capital Expenditures | $740.9M+21.8% | $608.5M+3.8% | $586.2M-7.2% | $631.6M-11.2% | $711.5M+1.9% | $698.1M-20.8% | $881.1M-8.9% | $967.4M-9.6% | $1.1B+48.0% | $722.9M+1.5% | $712.2M |
| Free Cash Flow | $7.8B-35.5% | $12.1B-7.6% | $13.1B+9.6% | $11.9B-3.9% | $12.4B-2.1% | $12.7B+14.6% | $11.1B-9.2% | $12.2B+97.5% | $6.2B+24.2% | $5.0B-20.5% | $6.2B |
| Investing Cash Flow | $1.9B+8.3% | $1.7Bn/m | -$377.2Mn/m | -$851.4Mn/m | -$1.5Bn/m | -$1.1Bn/m | -$847.9Mn/m | -$1.3Bn/m | -$25.1Bn/m | -$789.6Mn/m | -$5.9B |
| Financing Cash Flow | -$11.8Bn/m | -$13.3Bn/m | -$11.9Bn/m | -$10.7Bn/m | -$11.8Bn/m | -$10.8Bn/m | -$11.4Bn/m | -$12.3B-161.6% | $20.0Bn/m | -$5.2Bn/m | -$322.9M |
| Dividends Paid | $7.0B+7.9% | $6.5B+1.3% | $6.4B+8.5% | $5.9B-12.1% | $6.8B0.0% | $6.8B+10.8% | $6.1B+10.0% | $5.5B+18.4% | $4.7B+30.6% | $3.6B-12.1% | $4.1B |
| Share Buybacks | $82.0M-30.3% | $117.7M-16.0% | $140.2M+45.1% | $96.6M | N/A | N/A | $6.4B+4.0% | $6.2B-5.7% | $6.6B+9.7% | $6.0B-16.3% | $7.1B |
Not reported in any period shown, so not listed: Stock-Based Compensation.
BTI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 39.0%+28.5pp | 10.6%+68.3pp | -57.7%-95.8pp | 38.0%-1.8pp | 39.9%+1.2pp | 38.6%+3.8pp | 34.8%-3.2pp | 38.0%+5.2pp | 32.8%-0.2pp | 32.9%-3.4pp | 36.4% |
| Net Margin | 30.3%+18.5pp | 11.9%+64.5pp | -52.7%-76.8pp | 24.1%-2.4pp | 26.5%+1.6pp | 24.8%+2.8pp | 22.0%-2.6pp | 24.6% | 191.6% | 32.9%-1.3pp | 34.2% |
| Return on Equity | 16.9%+10.5pp | 6.4%+34.6pp | -28.2%-37.3pp | 9.0%-1.3pp | 10.4%+0.2pp | 10.2%+1.3pp | 8.9%-0.3pp | 9.2%-52.5pp | 61.7%+4.9pp | 56.8%-28.4pp | 85.3% |
| Return on Assets | 7.1%+4.5pp | 2.6%+14.7pp | -12.1%-16.4pp | 4.3%-0.6pp | 5.0%+0.3pp | 4.7%+0.6pp | 4.0%-0.1pp | 4.1%-22.4pp | 26.6%+14.9pp | 11.7% | N/A |
| Current Ratio | 0.87+0.1x | 0.76-0.1x | 0.910.0x | 0.860.0x | 0.850.0x | 0.88+0.2x | 0.71-0.1x | 0.78-0.1x | 0.90-0.1x | 1.04 | N/A |
| Debt-to-Equity | 0.690.0x | 0.680.0x | 0.70+0.2x | 0.530.0x | 0.55-0.1x | 0.640.0x | 0.59-0.1x | 0.66-0.1x | 0.72-1.3x | 2.02 | N/A |
| Liabilities-to-Equity | 1.37-0.1x | 1.48+0.1x | 1.33+0.2x | 1.080.0x | 1.10-0.1x | 1.200.0x | 1.210.0x | 1.24-0.1x | 1.32-2.5x | 3.86 | N/A |
| Asset Turnover | 0.230.0x | 0.220.0x | 0.230.0x | 0.180.0x | 0.190.0x | 0.190.0x | 0.180.0x | 0.170.0x | 0.14-0.2x | 0.36 | N/A |
| FCF Margin | 22.6%-14.6pp | 37.3%-0.3pp | 37.6%+1.9pp | 35.7%-0.1pp | 35.8%-0.2pp | 36.0%+3.8pp | 32.2%-6.7pp | 38.9%+15.7pp | 23.3%-5.2pp | 28.5%-5.3pp | 33.8% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Note: The current ratio is below 1.0 (0.87), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| British American Tobacco p.l.c. BTI | FY2025 | $34.4B | $10.4B | 30.3% | $130.0B | 41/100 |
| Altria Group, Inc. MO | FY2025 | $23.3B | $6.9B | 29.8% | $123.3B | 59/100 |
| Philip Morris International Inc. PM | FY2025 | $40.6B | $11.3B | 27.9% | $307.8B | 63/100 |
| RLX Technology Inc. RLX | FY2025 | $566.1M | $131.8M | 23.3% | $2.1B | 68/100 |
| Turning Point Brands, Inc. TPB | FY2025 | $463.1M | $58.2M | 12.6% | $1.3B | 79/100 |
| Anheuser-Busch InBev SA/NV BUD | FY2025 | $59.3B | $6.8B | 11.5% | $162.0B | 51/100 |
Where British American Tobacco p.l.c. Ranks
Frequently Asked Questions
What is British American Tobacco p.l.c.'s annual revenue?
British American Tobacco p.l.c. (BTI) reported $34.4B in total revenue for fiscal year 2025. This represents a 6.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is British American Tobacco p.l.c.'s revenue growing?
British American Tobacco p.l.c. (BTI) revenue grew by 6.3% year-over-year, from $32.4B to $34.4B in fiscal year 2025.
Is British American Tobacco p.l.c. profitable?
Yes, British American Tobacco p.l.c. (BTI) reported a net income of $10.4B in fiscal year 2025, with a net profit margin of 30.3%.
What is British American Tobacco p.l.c.'s EBITDA?
British American Tobacco p.l.c. (BTI) had EBITDA of $16.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does British American Tobacco p.l.c. have?
As of fiscal year 2025, British American Tobacco p.l.c. (BTI) had $5.1B in cash and equivalents against $42.6B in long-term debt.
What is British American Tobacco p.l.c.'s operating margin?
British American Tobacco p.l.c. (BTI) had an operating margin of 39.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is British American Tobacco p.l.c.'s net profit margin?
British American Tobacco p.l.c. (BTI) had a net profit margin of 30.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is British American Tobacco p.l.c.'s return on equity (ROE)?
British American Tobacco p.l.c. (BTI) has a return on equity of 16.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is British American Tobacco p.l.c.'s free cash flow?
British American Tobacco p.l.c. (BTI) generated $7.8B in free cash flow during fiscal year 2025. This represents a -35.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is British American Tobacco p.l.c.'s operating cash flow?
British American Tobacco p.l.c. (BTI) generated $8.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are British American Tobacco p.l.c.'s total assets?
British American Tobacco p.l.c. (BTI) had $147.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are British American Tobacco p.l.c.'s capital expenditures?
British American Tobacco p.l.c. (BTI) invested $740.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does British American Tobacco p.l.c. spend on research and development?
British American Tobacco p.l.c. (BTI) invested $481.4M in research and development during fiscal year 2025.
What is British American Tobacco p.l.c.'s current ratio?
British American Tobacco p.l.c. (BTI) had a current ratio of 0.87 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is British American Tobacco p.l.c.'s debt-to-equity ratio?
British American Tobacco p.l.c. (BTI) had a debt-to-equity ratio of 0.69 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is British American Tobacco p.l.c.'s liabilities-to-equity ratio?
British American Tobacco p.l.c. (BTI) had a liabilities-to-equity ratio of 1.37 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is British American Tobacco p.l.c.'s return on assets (ROA)?
British American Tobacco p.l.c. (BTI) had a return on assets of 7.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is British American Tobacco p.l.c.'s P/E ratio?
British American Tobacco p.l.c. (BTI) trades at 12.5x earnings, its market capitalization divided by $10.4B net income, FY2025. The market capitalization is $130.0B as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is British American Tobacco p.l.c.'s price-to-sales ratio?
British American Tobacco p.l.c. (BTI) trades at 3.8x sales, its market capitalization divided by $34.4B revenue, FY2025. The market capitalization is $130.0B as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is British American Tobacco p.l.c.'s Altman Z-Score?
British American Tobacco p.l.c. (BTI) has an Altman Z-Score of 1.73, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is British American Tobacco p.l.c.'s Piotroski F-Score?
British American Tobacco p.l.c. (BTI) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are British American Tobacco p.l.c.'s earnings high quality?
British American Tobacco p.l.c. (BTI) has an earnings quality ratio of 0.82x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can British American Tobacco p.l.c. cover its interest payments?
British American Tobacco p.l.c. (BTI) has an interest coverage ratio of 6.03x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is British American Tobacco p.l.c.?
British American Tobacco p.l.c. (BTI) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.